期刊文献+

急性冠脉综合征PCI治疗联合应用盐酸替罗非班对围手术期转归的影响 被引量:2

下载PDF
导出
摘要 目的探讨在急性冠脉综合征(ACS)患者经皮冠状动脉介入治疗(PCI)联合应用盐酸替罗非班对围手术期转归的影响。方法 40例PCI术前具有形成血栓的高危因素或PCI术时发现慢血流或血栓的ACS患者,应用盐酸替罗非班观察相关血管的血栓负荷、急性心肌梗死相关血管血流(TIMI血流)、术后主要不良心血管事件(MACE)。结果 40例ACS患者术中即刻造影均未见有明显的新发血栓形成,原有新鲜血栓消失,靶血管血流明显改善。术后40例患者住院期间未发生MACE与出血并发症。结论对ACS患者PCI围手术期存有靶血管高危因素的患者,应用盐酸替罗非班能够明显改善心肌组织再灌注水平,减少PCI治疗后的主要心血管不良事件的发生。
作者 张胜波
出处 《中国现代药物应用》 2015年第3期97-98,共2页 Chinese Journal of Modern Drug Application
  • 相关文献

参考文献5

二级参考文献39

  • 1宋玉娥,王琳,李芳,龚培力,王朝晖,党瑜华.盐酸替罗非班对急性冠状动脉综合征的疗效和安全性评价[J].临床心血管病杂志,2006,22(4):220-222. 被引量:71
  • 2SILBER S, ALBERTSSON P, AVILES F F, et al. Guidelines for pereutaneous coronary interventions. the task force for percutaneous coronary interventions of the european society of cardiology[J]. Eur Heart J, 2005, 26: 804-847.
  • 3TIMI study group. The thrombolysis in myocardial infarction (TIMI) trial; phase Ⅰ findings[J]. N Engl J Med, 1985, 312: 932-936.
  • 4GIBSON C M, CANNON C P, MURPHY S A, et al. Relationship of TIMI myocardial perfusiongrade to mortality after administration of thrombolytic drugs [J]. Circulation, 2000,101: 125-130.
  • 5CARR M E Jr. In vitro assessment of platelet function[J]. Transfus Med Rev, 1997,11: 106- 115.
  • 6RAZAKJR O A, TAN H C, YIP W L, et al. Predictors of bleeding complications and thrombocytopenia with the use of abciximab during percutaneous coronary intervention[J]. J Interv Cardiol, 2005,18 : 33- 37.
  • 7BOLOGNESE L, FALSINI G, LIISTRO F. Randomized comparison of upstream tirofiban versus downstream high bolus dose tirofiban or abciximab on tissue-level perfusion and troponin release in high-risk acute coronary syndromes treated with percutaneous coronary inteventions: the EVEREST trial[J]. J Am Coll Cardiol, 2006, 47: 522-528.
  • 8FERGUSON J J , ZAQQA M. Platelet glycoprotein GP Ⅱb/Ⅲa receptor anatagonists[J]. Drugs, 1999, 58: 965-982.
  • 9The RESTORE Investigators. Effects of platelet glycoprotein Ⅱb/Ⅲa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. Randomized efficacy study of tirofiban for outcomes and restenosis[J]. Circulation, 1997,96:1445-1453.
  • 10WARNHOLTZ A, OSTAD M A, HEITZER T, et al. Effect of tirofiban on percutaneous coronary intervention induced endothelial dysfunction in patient with stable coronary artery disease [J]. Am J Cardiol, 2005,95:20-23.

共引文献60

同被引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部